Evidently, an AI platform transforming healthcare workflows, has raised $15m in Series A funding in a round led by DN Capital.
The company aims to address critical healthcare data challenges by providing AI-driven solutions that synthesise disparate data sources to improve clinical decision-making.
The tranche also featured participation from FRAMEWORK, Clear Ventures, Fellows Fund, and existing investors.
The $15m investment will help Evidently scale its platform and meet the growing demand for its ‘EvidentlyOne’ product.
This follows significant financial and efficiency gains seen in leading US health systems that use the platform, which has reduced transplant referral chart prep time by over 90% and improved clients’ Case Mix Index accuracy.
The platform’s real-time decision support is designed to alleviate clinician burnout while improving institutional success.
Evidently’s offering uses AI to create actionable, concise summaries of healthcare data, bringing together various sources, including external health records and faxes. By doing so, it enables clinicians to focus on delivering better care.
With the new funding, the company plans to expand its capabilities, particularly in population health and clinical research, areas driven by the expertise of Chief Product Officer Kalie Dove-Maguire, MD.
Feng Niu, CEO of Evidently, said, “Clinicians are still overwhelmed by fragmented data and the pressure to meet institutional goals. While ambient scribes are great, they are just the beginning. Imagine an AI resident that helps you code accurately, identify clinical trial candidates, and make more informed decisions at the point of care. By automating low-level cognitive tasks, we’re empowering healthcare providers to focus on what matters most—delivering exceptional care. With this funding, we can meet the growing demand for our platform and create a future where advanced technology is accessible to all healthcare providers.”
The funding will also allow Evidently to continue innovating and expanding the platform’s reach across the US healthcare market. Gulsah Wilke, Partner at DN Capital, will join Evidently’s board of directors, bringing valuable insights from her previous role as COO at ADA Health.
Peter Misek, Managing Partner at FRAMEWORK, commented, “AI is a massive technological wave that has the opportunity to solve some of the world’s largest challenges. Healthcare is one such challenge and we believe Evidently’s Cognitive AI approach is a game-changer, setting itself apart from the other AI-powered tools in the ecosystem by taking a human-first approach to delivering measurable results for hospitals and health systems.”
The company was previously backed by investors such as Rajeev Madhavan, Partner at Clear Ventures, who added, “What sets Evidently apart is their ability to give physicians back their most precious resource – time. By automating low-level cognitive tasks and surfacing critical insights from unstructured medical data, they’re not just improving hospital revenues, but fundamentally changing how clinical teams work!”
Keep up with all the latest FinTech news here
Copyright © 2024 FinTech Global
